<!doctype html>
<html lang="en">
  <head>
	<meta name="generator" content="Hugo 0.137.1"><script src="/~taidang/cheapvs/livereload.js?mindelay=10&amp;v=2&amp;port=1313&amp;path=~taidang/cheapvs/livereload" data-no-instant defer></script>
    <meta charset="utf-8">
<title>Preferential Multi-Objective Bayesian Optimization for Drug Discovery</title>


<meta name="apple-mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no"><link rel="stylesheet" href="/~taidang/cheapvs/reveal-js/dist/reset.css">
<link rel="stylesheet" href="/~taidang/cheapvs/reveal-js/dist/reveal.css"><link rel="stylesheet" href="/~taidang/cheapvs/css/serif.css" id="theme"><link rel="stylesheet" href="/~taidang/cheapvs/highlight-js/default.min.css">
  </head>
  <body>
    
    <div class="reveal">
      <div class="slides">
  

    
<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<div style="text-align: left;">
  <h3 style="font-size: 1.5em;">Preferential Multi-Objective Bayesian Optimization for Drug Discovery</h3>
</div>
<p style="font-size: 30px;">
Tai Dang<sup>1,3</sup>,Hung Pham<sup>2</sup>,Sang Truong<sup>1</sup>, Ari Glenn<sup>1</sup>, Wendy Nguyen<sup>3</sup>, Edward A Pham<sup>1</sup>, Jeffrey S. Glenn<sup>1</sup>, Sanmi Koyejo<sup>1</sup>, Thang Luong<sup>1</sup> 
</p>
<p style="font-size: 30px;">
<sup>1</sup>Stanford University, <sup>2</sup>Imperial College London, <sup>3</sup>RHF.AI
</p>
<div style="display: flex; justify-content: space-between; width: 30%;">
  <img src="images/rhf.png" alt="Third Logo" style="height: 85px; margin-left: 10px; margin-top: 250px">
  <img src="images/SOM_vert_Web_Color_LG.png" alt="Main Logo" style="height: 85px; margin-left: 60px; margin-top: 250px"> 
  <img src="images/sail-logo.jpg" alt="Second Logo" style="height: 85px; margin-left: 75px; margin-top: 250px">
</div>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="outline">Outline</h3>
<ul>
<li>Problem Setup</li>
<li>Virtual Screening on Synthetic Functions</li>
<li>Chemist-guided Active Preferential Virtual Screening</li>
<li>Protein-ligand docking with Diffusion Models</li>
</ul>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="overview-problem-setup">Overview: Problem setup</h3>
<p>Traditional large-scale docking consumes extensive computational resources, making the process slow and costly.


<span class='fragment ' >Chemists manually evaluate thousands of molecules, selecting hits based on intuition.</span>




<span class='fragment ' >This step is critical yet slow, forming a major bottleneck.</span>



<span class='fragment ' >Experts must balance multiple drug properties (e.g., efficacy, safety, solubility),</span>




<span class='fragment ' >complicating decision-making and extending timelines in drug development.</span>

</p>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="overview">Overview</h3>
<section>
  <figure style="text-align: center; margin-top: 100px; position: relative;">
    <img src="figures/overview_nopointer.png" alt="Overview Image" style="width: 95%; max-width: 1000px;">
    <div style="position: absolute; top: 0; left: 28.5%; width: 70%; height: 100%; background: white;" class="fragment fade-out"></div>
    <div style="position: absolute; bottom: 0; left: 0; width: 100%; height: 56%; background: white;" class="fragment fade-out"></div>
    <div style="position: absolute; bottom: 0; left: 0; width: 45.9%; height: 55%; background: white;"></div>
  </figure>
  <figure style="text-align: center; margin-top: -579px; position: relative;" class="fragment fade-in">
    <img src="figures/overview.png" alt="Overview Image" style="width: 95%; max-width: 1000px;">
    <div style="position: absolute; bottom: 0; left: 0; width: 37.3%; height: 55%; background: white;" class="fragment fade-out"></div>
  </figure>
</section>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="overview-streamlining-virtual-screening-with-advanced-techniques">Overview: Streamlining Virtual Screening with Advanced Techniques</h3>
<div style="margin-top: 20px; display: flex; justify-content: space-between; align-items: flex-start;">
  <div style="width: 50%;">
    <h3 style="font-size: 36px;">Challenges:</h3>
    <ol style="font-size: 32px;">
      <li class="fragment" data-fragment-index="1">Conducting virtual screening within budget constraints.</li>
      <li class="fragment" data-fragment-index="2">Incorporating multiple objectives beyond affinity.</li>
      <li class="fragment" data-fragment-index="3">Training efficient docking models with limited resources.</li>
    </ol>
  </div>
  <div style="width: 50%;">
    <h3 style="font-size: 36px; padding-left: 30px;">Solutions:</h3>
    <ol style="font-size: 32px; padding-left: 30px;">
      <li class="fragment" data-fragment-index="1">Optimize ligand selection through active screening.</li>
      <li class="fragment" data-fragment-index="2">Utilize Preferential Multi-Objective Bayesian Optimization.</li>
      <li class="fragment" data-fragment-index="3">Enhance docking model through diffusion model.</li>
    </ol>
  </div>
</div>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="outline-1">Outline</h3>
<ul>
<li>Problem Setup</li>
<li><span style="opacity: 0.5;">Virtual Screening on Synthetic Functions</span></li>
<li><span style="opacity: 0.5;">Chemist-guided Active Preferential Virtual Screening</span></li>
<li><span style="opacity: 0.5;">Protein-ligand docking with Diffusion Models</span></li>
</ul>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="1-problem-setup">1. Problem Setup</h3>
<p>For <strong>a given protein</strong> linked to a certain disease,


<span class='fragment ' >the goal of virtual screening is to select a <strong>few</strong> small molecules (i.e., ligand)</span>




<span class='fragment ' >from a library of <strong>millions</strong> candidates</span>




<span class='fragment ' >such that the selected candidate will have the <strong>highest utility</strong> in disease treating.</span>

</p>


<span class='fragment ' ><figure style="display: flex; flex-direction: column; align-items: center; width: 90%; margin-top: 0px; margin-left: 60px">
<img src="figures/vs.png">
<figcaption style="text-align: center; font-size: 20px; margin-top: 0px;">
    Traditional Virtual Screening Process
    <br>
    <span style="font-size: 16px;">Source: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8188596/">Graff et al., 2021</a></span>
</figcaption>
</span>


</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="1-problem-setup-1">1. Problem Setup</h3>
<p>

<span class='fragment ' >Docking consumes vast computational resources on low-scoring compounds, though only top-ranked molecules advance for validation.</span>




<span class='fragment ' >To refine this process, virtual screening includes <b>hit identification</b>, where chemists select promising compounds based on ligand properties.</span>

</p>
<p>

<span class='fragment ' >Even with expert-defined trade-offs, exhaustively screening millions of candidates is infeasible.</span>




<span class='fragment ' >To address this, we prioritize promising ligands while avoiding those likely to be poor candidates.</span>

</p>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="2-active-virtual-screening">2. Active Virtual Screening</h3>
<p>

<span class='fragment ' >To prioritize high-potential ligands, we use <strong>Preferential Bayesian Optimization</strong>,</span>




<span class='fragment ' >an approach that balances exploring new candidates and exploiting known promising ones to efficiently find optimal solutions.</span>

</p>


<span class='fragment ' ><img src="figures/cheapvs1.png" alt="Active Virtual Screening Diagram" style="display: block; margin: 0 auto; width: 65%;" class="fragment">
</span>


</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="1-problem-setup-2">1. Problem Setup</h3>
<p>Learning a preference model from binary preference data can be viewed as learning a classifier.</p>


<span class='fragment ' ><p>$$p(y \mid x_1, x_2; f) = \frac{e^{f(x_1)}}{e^{f(x_1)} + e^{f(x_2)}}$$</p>
</span>




<span class='fragment ' ><p>$$= \frac{1}{1 + e^{-[f(x_1)-f(x_2)]}}$$</p>
</span>




<span class='fragment ' ><p>$$= \sigma(f(x_1)-f(x_2))$$</p>
</span>




<span class='fragment ' >where $\sigma(\cdot)$ is the sigmoid function.</span>


</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="1-problem-setup-3">1. Problem Setup</h3>
<p><b>Goal:</b> Identify the top <i>k</i> candidate ligands for a given protein from a library.</p>
<li class="fragment"><b>Step 1:</b> Start with a ligand library $\mathcal{L} = \{ l_1, \dots, l_N \}$ and a empty dataset $\mathcal{D}$.  </li>
<li class="fragment"><b>Step 2:</b> Select a subset $\mathcal{D}_i = \{ l_i, l_k, l_f, \dots \}$  using an acquisition function $\alpha$, update the dataset $\mathcal{D} \leftarrow \mathcal{D} \cup \mathcal{D}_i$
  and remove these ligands from $\mathcal{L} \leftarrow \mathcal{L} \setminus \mathcal{D}_i$.
</li>
<li class="fragment"><b>Step 3:</b> Dock ligands in $\mathcal{D}_i$ using a docking model $\theta$ to estimate binding affinity.</li>
<li class="fragment"><b>Step 4:</b> Train a GP $g$ on ligand fingerprints $t$ to predict affinity: $ g(t) \sim \mathcal{GP}(\mu, k) $
</li>
<li class="fragment"><b>Step 5:</b> Compute additional ligand properties (e.g., solubility, toxicity).</li>
<li class="fragment"><b>Step 6:</b> Train a GP $f$ with pairwise preferences from ligand properties:  
  $$ f(\mathbf{x}) \sim \mathcal{GP}(\mu, k) \quad \text{and} \quad p(y=1 \mid \mathbf{x}_1, \mathbf{x}_2) = \sigma(f(\mathbf{x}_1) - f(\mathbf{x}_2)) $$
</li>
<li class="fragment"><b>Step 7:</b> Return to Step 2 or terminate if the computational budget is reached.</li>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="overview-1">Overview</h3>
<figure style="text-align: center; margin-top: 0px; position: relative;" class="fragment fade-in">
  <img src="figures/overview.png" alt="Overview Image" style="width: 95%; max-width: 1000px;">
</figure>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="outline-2">Outline</h3>
<ul>
<li><span style="opacity: 0.5;">Problem Setup</span></li>
<li>Virtual Screening on Synthetic Functions</li>
<li><span style="opacity: 0.5;">Chemist-guided Active Preferential Virtual Screening</span></li>
<li><span style="opacity: 0.5;">Protein-ligand docking with Diffusion Models</span></li>
</ul>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="2-active-virtual-screening-experiment-setup">2. Active Virtual Screening: Experiment Setup</h3>
<p>Synthetic Utility Landscapes</p>
<ul>
  <li class="fragment">Testing synthetic functions helps refine the approach before human experiments.</li>
  <li class="fragment">Benchmarks: Ackley, Alpine1, Hartmann, Dropwave, Qeifail, Levy.</li>
  <li class="fragment">Each benchmark outputs a scalar utility for preference-based learning.</li>
  <li class="fragment">Simulated objectives: affinity, rotatable bonds, molecular weight, LogP.</li>
  <li class="fragment">20K-ligand subset used for computational efficiency.</li>
</ul>


<span class='fragment ' ><figure style="display: flex; flex-direction: column; align-items: center;">
  <div style="display: flex; justify-content: center; width: 100%; gap: 70px;">
      <img src="figures/synthetic_funcs.png" style="width: 100%; max-width: 1000px;">
  </div>
  <figcaption style="text-align: center; font-size: 20px; margin-top: 0px;">Synthetic functions landscape.</figcaption>
</figure>
</span>


</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="2-active-virtual-screening-evaluation-metrics">2. Active Virtual Screening: Evaluation Metrics</h3>
<p><strong>Metrics for evaluation</strong>


<span class='fragment ' ><p><strong>Regret</strong></p>
</span>

</p>
<ul>
  <li class="fragment">$R_i = U^* - U(i)$</li>
  <li class="fragment">Where $U^*$ is the highest possible utility in the library and $U(i)$ is the highest utility found by the model at iteration $i$</li>
</ul>


<span class='fragment ' ><p><strong>Percent of Best Ligand Found</strong></p>
</span>


<ul>
  <li class="fragment"><b>Definition</b>: Percentage of screened ligands close in affinity to the best possible ligand. ($top_k \%$)</li>
</ul>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="2-active-virtual-screening-screening-results">2. Active Virtual Screening: Screening Results</h3>


<span class='fragment ' ><figure style="display: flex; flex-direction: column; align-items: center;">
  <div style="display: flex; justify-content: center; width: 100%; gap: 70px;">
      <img src="figures/regret.png" style="width: 65%; max-width: 1000px;">
  </div>
  <figcaption style="text-align: center; font-size: 20px; margin-top: 0px;">Preferential Multi-Objective Optimization results on synthetic functions with different docking models.</figcaption>
</figure>
</span>


</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="outline-3">Outline</h3>
<ul>
<li><span style="opacity: 0.5;">Problem Setup</span></li>
<li><span style="opacity: 0.5;">Virtual Screening on Synthetic Functions</span></li>
<li>Chemist-guided Active Preferential Virtual Screening</li>
<li><span style="opacity: 0.5;">Protein-ligand docking with Diffusion Models</span></li>
</ul>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="3chemist-guided-active-preferential-virtual-screening-overview">3.Chemist-guided Active Preferential Virtual Screening: Overview</h3>
<p>

<span class='fragment ' >In drug discovery, selecting candidate ligands goes beyond targeting high-affinity molecules.</span>




<span class='fragment ' >Experts use their deep chemical intuition to balance competing properties such as synthesizability, solubility, and potential side effects.</span>




<span class='fragment ' >This approach ensures ligands are not only effective but also practical and safe for therapeutic use.</span>

</p>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="3cheapvs">3.CheapVS</h3>
<p>
  Depending on the disease and target protein, experts have <b>intuition</b> about ligand characteristics,  
  

<span class='fragment ' >balancing synthesizability, affinity, solubility, and side effects.</span>

  
  

<span class='fragment ' >For instance, bulky functional groups can enhance binding but reduce solubility or increase toxicity, complicating optimization.</span>

  
</p>


<span class='fragment ' ><div style="display: flex; justify-content: center; width: 100%; gap: -30px; margin-top: -100px;">
  <figure style="display: flex; flex-direction: column; align-items: center; width: 45%;">
    <img src="figures/lig1.png" style="width: 100%;" alt="Aff: -10.11, PSA: 67.66">
    <figcaption style="text-align: left; font-size: 20px; margin-top: -50px;">Affinity: -10.11, Solubility: 67.66</figcaption>
  </figure>
  <figure style="display: flex; flex-direction: column; align-items: center; width: 45%;">
    <img src="figures/lig2.png" style="width: 100%;" alt="Aff: -6.3, Solubility: 128.37">
    <figcaption style="text-align: left; font-size: 20px; margin-top: -50px;">Affinity: -6.3, Solubility: 128.37</figcaption>
  </figure>
</div>
</span>


</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="3cheapvs-1">3.CheapVS</h3>
<p>

<span class='fragment ' >These implicit expert knowledge, encoded as preferences over ligands, are valuable to elicit for effective virtual screening.</span>




<span class='fragment ' >We can leverage toolkits from the field of machine learning from human preferences to tackle this challenge.</span>


<span class="fragment"></p>
<table style="width: 90%; margin-top: 20px; border-collapse: collapse; text-align: center; font-size: 24px;">
  <tr>
    <th style="border: 1px solid #ddd; padding: 8px;">First ligand</th>
    <th style="border: 1px solid #ddd; padding: 8px;">Second ligand</th>
    <th style="border: 1px solid #ddd; padding: 8px;">Preference $(x_1 \succ x_2)$</th>
  </tr>
  <tr>
    <td style="border: 1px solid #ddd; padding: 8px;">[-7.81, 113.38, 0.51]</td>
    <td style="border: 1px solid #ddd; padding: 8px;">[-8.12, 116.28, 0.47]</td>
    <td style="border: 1px solid #ddd; padding: 8px;">0</td>
  </tr>
  <tr>
    <td style="border: 1px solid #ddd; padding: 8px;">[-10.45, 186.17, 0.29]</td>
    <td style="border: 1px solid #ddd; padding: 8px;">[-8.12, 116.28, 0.47]</td>
    <td style="border: 1px solid #ddd; padding: 8px;">1</td>
  </tr>
  <tr>
    <td style="border: 1px solid #ddd; padding: 8px;">[-6.18, 35.32, 0.83]</td>
    <td style="border: 1px solid #ddd; padding: 8px;">[-8.12, 116.28, 0.47]</td>
    <td style="border: 1px solid #ddd; padding: 8px;">0</td>
  </tr>
</table>
<p style="font-size: 24px; text-align: center; margin-top: 15px;">
  <em>Each ligand is represented by a set of features, such as affinity, polar surface area, QED drug-likeness score</em>
</p>
</span>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="3cheapvs-2">3.CheapVS</h3>
<img src="figures/app.png" alt="app" style="display: block; margin: 0px auto 0 auto; width: 70%;">
<figcaption style="text-align: center; font-size: 28px; margin-top: 10px;">App for interacting with Chemists.
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="3cheapvs-experiment-setup">3.CheapVS: Experiment Setup</h3>
<p>BO Optimization for EGFR</p>
<p><b>EGFR (Epidermal Growth Factor Receptor)</b> is a protein that regulates cell growth. Mutations in EGFR are linked to cancers.</p>
  <ul>
    <li class="fragment">Screening library: 100K molecules.</li>
    <li class="fragment">37 FDA-approved or late-stage drugs as goal-optimal molecules.</li>
    <li class="fragment">Expert-labeled preferences for multi-objective optimization.</li>
    <li class="fragment">4 Objectives: Affinity, Molecular Weight, Lipophilicity, Half-life.</li>
    <li class="fragment">BO samples 1%, adds 0.5% per iteration (10 iterations, 6% total).</li>
  </ul>
</section>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="3cheapvs-results">3.CheapVS: Results</h3>
<img src="figures/cheapvs_main.png" alt="cheapvs_main" style="display: block; margin: 50px auto 0 auto; width: 60%;">
<figcaption style="text-align: left; font-size: 23.5px; margin-top: 10px;">Performance of CheapVS in identifying EGFR drugs. The plot compares docking models and objectives. Multi-objective optimization outperforms the rest, identifying up to 16 of 37 approved drugs.
</figcaption> 
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="3cheapvs-gp-elicitation">3.CheapVS: GP Elicitation</h3>
<img src="figures/elicitation.png" alt="cheapvs_main" style="display: block; margin: 50px auto 0 auto; width: 60%;">
<figcaption style="text-align: left; font-size: 23.5px; margin-top: 10px;">Predictive utility scores after BO on expert preference elicitation. The box plot contrasts drugs vs. non-drugs, while heatmaps show utility across two objectives. Results align with medicinal chemistry ranges.
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="outline-4">Outline</h3>
<ul>
<li><span style="opacity: 0.5;">Problem Setup</span></li>
<li><span style="opacity: 0.5;">Virtual Screening on Synthetic Functions</span></li>
<li><span style="opacity: 0.5;">Chemist-guided Active Preferential Virtual Screening</span></li>
<li>Protein-ligand docking with Diffusion Models</li>
</ul>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="4-diffusion-model-noise-to-pattern">4. Diffusion Model: Noise to pattern</h3>


<span class='fragment ' ><strong>Diffusion models</strong> are a type of machine learning model used to generate data by starting with noise and gradually creating a meaningful pattern.</span>




<span class='fragment ' ><figure style="display: flex; flex-direction: column; align-items: center; width: 80%; margin-left: 80px;"> 
  <img src="figures/cat.gif" alt="Diffusion Process" style="width: 30%;"> 
  <figcaption style="text-align: center; font-size: 24px; margin-top: 10px;">Transforming noise into meaningful structures.</figcaption> 
</figure> 
</span>


</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="4-diffusion-model-why-used-for-docking">4. Diffusion Model: Why used for docking?</h3>
<p>Why Use Diffusion Models for Molecules?</p>


<span class='fragment ' ><figure style="display: flex; flex-direction: column; align-items: center; width: 100%; margin-top: 0px;">
  <img src="figures/molecular_diffusion.png" alt="Molecular Diffusion Process" style="width: 100%;">
  <figcaption style="text-align: center; font-size: 24px; margin-top: 0px;">From random points to a structured 3D molecule.</figcaption>
</figure>
</span>


</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="4-diffusion-model-training-data">4. Diffusion Model: Training Data</h3>


<span class='fragment ' ><p>The PDB database is limited:</p>
<ul>
<li>Contains only ~17,000 protein-ligand pairs.</li>
<li>Features around 5,000 unique proteins.</li>
</ul>
</span>




<span class='fragment ' ><p>For robust diffusion model training, millions of diverse data points are needed. Data augmentation enhances:</p>
<ul>
<li><strong>Ligand Diversity</strong>: Broader chemical structure and property range.</li>
<li><strong>Protein Diversity</strong>: Wider variety of binding sites for better model generalization.</li>
</ul>
</span>




<span class='fragment ' ><p>Data augmentation techniques create a richer dataset, boosting model performance.</p>
</span>


</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="4-diffusion-model-training-data-1">4. Diffusion Model: Training Data</h3>


<span class='fragment ' ><p><strong>Data Augmentation Techniques</strong>:</p>
<ul style="font-size: 26px"> 
    <li class="fragment"><b>Molecular Dynamics:</b> Employed 59,330 dynamic frames of 14,387 protein-ligand complexes to model ligand flexibility, amounting to 75K training data.</li> 
    <li class="fragment"><b>Data Crawling:</b> Curated 322K protein-ligand complexes, yielding 80K unique proteins.</li>
    <li class="fragment"><b>Pharmacophore Alignment:</b> Generated up to 11M pharmacophore-consistent ligand pairs, significantly expanding the ligand training data.</li> 
</ul> 
</span>




<span class='fragment ' ><div style="display: flex; justify-content: space-between; margin-top: 20px;">
    <div style="width: 49%;">
        <img src="figures/md1.gif" alt="MD Simulation Example" style="width: 55%; height: auto; margin-left: 100px; margin-top: -20px;">
        <p style="text-align: center; font-size: 20px; margin-left: -130px; margin-top: -40px;">Figure 1: MD Simulation Trajectories</p>
    </div>
    <div style="width: 49%;">
        <img src="figures/pharmacophore.png" alt="Pharmacophore Model Example" style="width: 80%; height: auto;">
        <p style="text-align: center; font-size: 20px; margin-top: 10px;">Figure 2: Pharmacophore Modeling</p>
    </div>
</div>
</span>


</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="4-diffusion-model-results">4. Diffusion Model: Results</h3>
<p><strong>Benchmark on Posebusters Dataset</strong>:


<span class='fragment ' >Posebusters: Version 1 (428 structures) and Version 2 (308 structures), released post-2021 in PDB.</span>




<span class='fragment ' >Performance: % of ligand pairs with $RMSD &lt; 2 Ã…$ in pocket alignment.</span>

</p>


<span class='fragment ' ><figure style="text-align: center; margin-top: -20px; position: relative;">
  <img src="figures/docking_results.png" alt="Docking Results" style="width: 100%; max-width: 1000px;">
</figure>
</span>


</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="4-diffusion-model-neural-search-for-docking">4. Diffusion Model: Neural Search for Docking</h3>


<span class='fragment ' ><p>Traditional docking tools are slow, limiting the efficiency of application of virtual screening.</p>
</span>


<ul> 
  <li class="fragment"><b>Traditional Tools</b> (e.g., Vina, Smina): ~5mins per pose</li> 
  <li class="fragment"><b>Chai</b> (AlphaFold3-like): ~1 mins for 1 pose (5x faster)</li> 
  <li class="fragment"><b>Our Diffusion Model</b>: ~10s for 128 poses (90x faster)</li> 
</ul>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="5-conclusion">5. Conclusion</h3>
<ul>
    <li class="fragment"><b>Efficient Drug Discovery:</b> Our framework accelerates VS by leveraging preferential multi-objective BO, requiring only a small subset of ligands and expert pairwise preferences.</li>
    <li class="fragment"><b>Strong Performance:</b> Our algorithm successfully identified 16/37 drugs, significantly outperforming baseline methods, highlighting the power of preference-based optimization.</li>
</ul>
</section>

<section data-noprocess data-shortcode-slide
      data-auto-animate="">
  
<h3 id="6-next-steps">6. Next steps</h3>
<ul> 
  <li class="fragment">Listwise preference for providing richer preference information</li>
  <li class="fragment">Build on top of state-of-the-art models such as AlphaFold3</li> 
</ul></section>

  


</div>
      

    </div>
<script type="text/javascript" src=/~taidang/cheapvs/reveal-hugo/object-assign.js></script>


<script src="/~taidang/cheapvs/reveal-js/dist/reveal.js"></script>


  <script type="text/javascript" src="/~taidang/cheapvs/reveal-js/plugin/markdown/markdown.js"></script>
  
  <script type="text/javascript" src="/~taidang/cheapvs/reveal-js/plugin/highlight/highlight.js"></script>
  
  <script type="text/javascript" src="/~taidang/cheapvs/reveal-js/plugin/zoom/zoom.js"></script>
  
  <script type="text/javascript" src="/~taidang/cheapvs/reveal-js/plugin/notes/notes.js"></script>
  
<script type="text/javascript">
  
  
  function camelize(map) {
    if (map) {
      Object.keys(map).forEach(function(k) {
        newK = k.replace(/(\_\w)/g, function(m) { return m[1].toUpperCase() });
        if (newK != k) {
          map[newK] = map[k];
          delete map[k];
        }
      });
    }
    return map;
  }

  var revealHugoDefaults = { center: true, controls: true, history: true, progress: true, transition: "slide" };
  var revealHugoSiteParams = {"custom_theme":"css/serif.css","enablesourcemap":true,"history":true,"margin":0.1,"slide_number":true};
  var revealHugoPageParams = {};

  var revealHugoPlugins = {
    
    plugins: [RevealMarkdown,RevealHighlight,RevealZoom,RevealNotes]
  };

  
  var options = Object.assign({},
    camelize(revealHugoDefaults),
    camelize(revealHugoSiteParams),
    camelize(revealHugoPageParams),
    camelize(revealHugoPlugins));

  Reveal.initialize(options);
</script>





  
  
    
  

  
  

  
  





<script>
  MathJax = {
    tex: {
      inlineMath: [['$', '$'], ['\\(', '\\)']]
    },
    svg: {
      fontCache: 'global'
    }
  };
</script>
  

<script type="text/javascript" id="MathJax-script" async src="/~taidang/cheapvs/tex-svg_7522271970123696654.js"></script>

    
    
  </body>
</html>
